Stocks and Investing Stocks and Investing
Wed, August 5, 2015
Tue, August 4, 2015

Christopher Raymond Maintained (BMRN) at Buy with Increased Target to $168 on, Aug 4th, 2015


Published on 2024-10-25 09:36:33 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $163 to $168 on, Aug 4th, 2015.

Christopher has made no other calls on BMRN in the last 4 months.



There are 5 other peers that have a rating on BMRN. Out of the 5 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Christopher


  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $156 on, Thursday, June 18th, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $151 on, Thursday, June 18th, 2015
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $156 on, Thursday, June 18th, 2015
  • Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $145 on, Thursday, June 18th, 2015
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Thursday, June 18th, 2015
Contributing Sources